‌

US Patent 12091442 Activatable cytokine constructs and related compositions and methods

Patent 12091442 was granted and assigned to CytomX Therapeutics on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
1
Current Assignee
CytomX Therapeutics
CytomX Therapeutics
1
Date Filed
May 25, 2022
1
Date of Patent
September 17, 2024
1
Patent Applicant
CytomX Therapeutics
CytomX Therapeutics
1
Patent Application Number
17824294
1
Patent Citations
‌
US Patent 8513390 Modified antibody compositions, methods of making and using thereof
1
‌
US Patent 7465790 Therapeutic antibodies
1
‌
US Patent 7695936 Knobs and holes heteromeric polypeptides
1
‌
US Patent 8399219 Protease activatable interferon alpha proprotein
1
‌
US Patent 9675672 Compositions and methods for modulating gamma-C-cytokine activity
1
‌
US Patent 10059762 Anti-EGFR activatable antibodies
1
‌
US Patent 10077300 Activatable binding polypeptides and methods of identification and use thereof
1
‌
US Patent 10118961 Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
1
‌
US Patent 10513549 Cleavage-activatable interferon-alpha proprotein
1
‌
US Patent 10683368 Fc-region variants with modified FcRn-binding and methods of use
1
•••
Patent Inventor Names
Hikmat Haizar Assi
1
Walter A. Bogdanoff
1
Na Cai
1
Hsin Wang
1
Sayantan Mitra
1
Nicole G. Lapuyade
1
Erwan Le Scolan
1
Dylan L. Daniel
1
Madan M. Paidhungat
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
12091442
1
Patent Primary Examiner
‌
Ruixiang Li
1

Find more entities like US Patent 12091442 Activatable cytokine constructs and related compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.